» Articles » PMID: 26476768

Echocardiographic Evidence of Right Ventricular Functional Improvement After Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Hypertension

Overview
Publisher Elsevier
Date 2015 Oct 19
PMID 26476768
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Chronic thromboembolic pulmonary hypertension (CTEPH) induces right ventricular (RV) adaptive changes but often results in RV failure and death. Balloon pulmonary angioplasty (BPA) is a treatment option in patients in whom pulmonary endarterectomy is contraindicated and in patients with residual pulmonary hypertension after pulmonary endarterectomy. We hypothesized that RV reverse remodeling and improved RV function would occur after BPA in patients with CTEPH.

Methods: In 26 patients with CTEPH (59 ± 12 years old; 11 men), echocardiography, cardiopulmonary exercise testing, blood samples, and right-sided cardiac catheterization were performed before and after 4 ± 2 BPA procedures. Echocardiography images were analyzed off-line with particular focus on RV function according to current recommendations. Differences from baseline to follow-up were analyzed by paired samples t tests.

Results: Significant improvements in hemodynamics, peak oxygen consumption, and levels of N-terminal pro-B-type natriuretic peptide were detected after BPA. All measures of RV function improved considerably, including fractional area change (+6%; p = 0.003), tricuspid annular plane systolic excursion (+3 mm; p < 0.001), and RV free wall peak strain (-4.4; p = 0.002). RV end-diastolic diameter, area, and free wall thickness decreased significantly, whereas left ventricular diameter and stroke volume increased.

Conclusions: After BPA, a significant improvement in RV functional parameters could be observed by echocardiography, adding credibility to this form of treatment in patients with CTEPH.

Citing Articles

Improvements in Hemodynamics and Right Heart Remodeling Following Balloon Pulmonary Angioplasty Treatment in Patients With Chronic Thromboembolic Pulmonary Hypertension: A Retrospective Study.

Shen Q, Zhao Q, Li H, Deng J, He J, Wang L Health Sci Rep. 2024; 7(11):e70159.

PMID: 39540028 PMC: 11558259. DOI: 10.1002/hsr2.70159.


Better efficacy of sequential combination with balloon pulmonary angioplasty after long-term riociguat for patients with inoperable chronic thromboembolic pulmonary hypertension.

Wang W, Wang J, Yang S, Kuang T, Li Y, Gong J Pulm Circ. 2024; 14(3):e12429.

PMID: 39188536 PMC: 11345204. DOI: 10.1002/pul2.12429.


Interventional Imaging Roadmap to Successful Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension.

Patel N, Hyder S, Michaud E, Moles V, Agarwal P, Rosenfield K J Soc Cardiovasc Angiogr Interv. 2024; 1(6):100429.

PMID: 39132377 PMC: 11307535. DOI: 10.1016/j.jscai.2022.100429.


Effects of right ventricular remodeling in chronic thromboembolic pulmonary hypertension on the outcomes of balloon pulmonary angioplasty: a 2D-speckle tracking echocardiography study.

Ma Y, Guo D, Wang J, Gong J, Hu H, Zhang X Respir Res. 2024; 25(1):164.

PMID: 38622598 PMC: 11020924. DOI: 10.1186/s12931-024-02803-4.


Optimal short-term outcomes in balloon pulmonary angioplasty: the minimum frequency of three sessions annually.

Li X, Yang T, Zhang Y, Zhao Q, Zeng Q, Jin Q Ther Adv Respir Dis. 2024; 18:17534666241232521.

PMID: 38409856 PMC: 10898305. DOI: 10.1177/17534666241232521.